Clinical Trial Update: Phosphorus 32 in Treating Patients With Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes a Phase 1 study evaluating phosphorus-32 for treating glioblastoma and currently lists an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Phosphorus-32 (phosphorus-32)

Snippet

Sponsor: Center for Molecular Medicine | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: UNKNOWN